Drugs - Aug 2019
- ARQon

- Aug 30, 2019
- 1 min read
Updated: Jan 8, 2020
China : NMPA No. 2019/34 Issuance of Provision n Drug Quality Inspection and and Testing
EU/US : EMA/FDA Analysis Shows High Degree of Alignment in Marketing Application Decisions Between EU and US.
South Korea : Five-year Master Plan for Clinical Trials Development
Thailand : Criteria and Conditions for Drug Dossier Registration Review, Draft version
Contact us at info@arqon.com.
.png)



Comments